Meeting
2021 ASCO Annual Meeting
Management impact of preoperative germline genetic testing in patients with breast cancer at the Lifespan Cancer Institute.
Authors
Kaitlyn P. Lew
Brown University, Providence, RI
Kaitlyn P. Lew , Don S. Dizon , Chanika Phornphutkul , Cindy Benson , Doreen Leyden Wiggins , Mary Anne Anne Fenton , Charu Taneja , Lauren J. Massingham
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Genetics
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 10523)
DOI
10.1200/JCO.2021.39.15_suppl.10523
Abstract #
10523
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2015 Breast Cancer Symposium
Surgical decisions of newly diagnosed breast cancer patients following genetic referral.
First Author: Jennifer McAlister
Poster
2024 ASCO Annual Meeting
Variant of uncertain significance (VUS) genetic testing results and mastectomy choice in lumpectomy-eligible patients.
First Author: Osvaldo Nunez Jr. Jr.
Poster
2023 ASCO Annual Meeting
Implementation of universal pan-cancer germline genetic testing in an Arab population: The Jordanian Exploratory Cancer Genetics (Jo-ECAG) study.
First Author: Hikmat Abdel-Razeq
Poster
2022 ASCO Annual Meeting
Improving access to cancer genetic testing for underserved women in southeast Texas.
First Author: Darya Aleksandrovna Kizub